相关实验视频
Updated: Jan 9, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.5K
粘膜黑色素瘤:其病因,进展,耐药性和治疗的机制
Sofie-Yasmin Hassan1, Thomas W Flanagan2, Sarah-Lilly Hassan3
1Pharmacy, Heinrich Heine University Duesseldorf, Universitaetsstr. 1, 40225 Duesseldorf, Germany.
Cells
|December 10, 2025
概括
粘膜黑色素瘤 (MM) 是一种罕见的癌症,发病率正在增加. 本综述涵盖了MM的生物学,发育,进展和耐治疗性,突出了其侵略性和较低的生存率,与皮肤黑色素瘤相比.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 病理学 病理学 病理学
背景情况:
- 粘膜黑色素瘤 (MM) 是一种罕见且具有攻击性的癌症亚型.
- 它的发病率正在增加,影响呼吸道,胃肠道和泌尿器官的无毛粘膜表面.
- 与皮肤黑色素瘤 (CM) 相比,MM表现出不同的流行病学,遗传学和临床表现.
研究的目的:
- 为了提供一个全面的概述的粘膜黑色素瘤 (MM) 生物学.
- 阐明调节MM发展和进展的机制.
- 审查MM的治疗耐药性.
主要方法:
- 关于粘膜黑色素瘤现有研究的文献综述.
- 对流行病学数据和遗传特征进行分析.
- 综合关于临床表现和治疗结果的信息.
主要成果:
- 麻疹由皮外粘膜部位的黑色素细胞引起.
- 与CM相比,MM的治疗响应率较低,存活率较差.
- 在MM和CM之间存在生物学和遗传学的关键差异.
结论:
- 了解MM生物学对于改善患者的治疗结果至关重要.
- 需要对MM特定机制进行进一步的研究.
- 需要有针对性的治疗策略来克服MM的治疗耐药性.
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K

